QuidelOrtho Partners With BYG4lab to Strengthen Informatics Offerings

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has entered into a software development partnership with BYG4lab, a leading provider of middleware and data management solutions for laboratories, that intends to accelerate QuidelOrtho’s efforts to expand and strengthen informatics offerings across its portfolio of diagnostics platforms.

“Our partnership with BYG4lab reaches across the business, from clinical labs to transfusion medicine to point-of-care, and it allows QuidelOrtho to rapidly integrate affordable, cutting-edge and time-saving informatics solutions,” said Douglas Bryant, President and Chief Executive Officer of QuidelOrtho. “Building this powerful data management capability into our portfolio offering will be yet another proof point in our commitment to engineering user-friendly innovations that enable customers to standardize and automate manual processes to boost efficiencies at single sites and across networks.”

QuidelOrtho’s partnership with BYG4lab, a proven company that understands the data management challenges labs face, expands on an existing agreement between both companies pertaining to France and is a strategic catalyst that will accelerate the development of innovative solutions that can be used across the entire lab. The companies will work jointly to address the immediate workflow and labor challenges within the global laboratory community through proprietary tools that allow auto-verification to become more routine and available to labs of all sizes. This partnership reflects QuidelOrtho’s appreciation of the importance of informatics to today’s labs and the Company’s determination to create robust solutions that are agile and can be updated quickly and easily to support our customers’ needs.

“With ever-increasing testing demands and decreasing staffing availability, accurate and automated record collection and management are critical to assuring the highest quality of patient care,” Mr. Bryant noted. “QuidelOrtho is committed to provide integrated diagnostics systems and informatics solutions that bridge the gap and give our customers an edge.”

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.